Vanda Pharmaceuticals Inc.
VNDA
$4.98
$0.061.22%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -853.29% | -239.24% | -173.32% | -130.64% | -60.02% |
| Total Depreciation and Amortization | 170.17% | 190.93% | 126.94% | 68.97% | 10.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -80.46% | -125.00% | -89.71% | -63.61% | -52.50% |
| Change in Net Operating Assets | -777.91% | 9.36% | -117.28% | -156.13% | -112.30% |
| Cash from Operations | -223.09% | -168.10% | -112.59% | -119.14% | -59.98% |
| Capital Expenditure | 95.33% | -26,725.19% | -20,264.80% | -15,733.44% | -14,781.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -114.28% | -62.61% | 25.28% | -150.16% | 75.86% |
| Cash from Investing | -44.58% | -160.85% | -183.79% | -196.12% | -124.15% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -446.81% | 136.25% | -100.38% | -103.27% | -82.26% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4,330.43% | -161.81% | -151.31% | -179.74% | -99.04% |
